HUTCHMED (China) (HCM) Reports 2023 Interim Results; Provides Business Updates

Go back to HUTCHMED (China) (HCM) Reports 2023 Interim Results; Provides Business Updates

HUTCHMED Reports 2023 Interim Results and Provides Business Updates

July 31, 2023 7:41 AM EDT

Strong execution on strategic direction, delivering near-term value while charting a path for growth, exemplified by global partnership with Takeda

Revenue grew 164% (173% CER) to US$533 million, with net income to HUTCHMED of US$169 million (which include US$259 million of the upfront recognized from Takeda)

Company to Host Interim Results Call & Webcast Today at 8 p.m. HKT / 1 p.m. BST / 8 a.m. EDT

Company to host a Capital Markets Day in Q4 this year

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July... More